We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers


0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bayer AG XE:BAYN Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Bayer Hit by Around $2.5 Billion of Impairments at Ailing Crop Business

08/08/2023 7:43am

Dow Jones News

Bayer (XE:BAYN)
Historical Stock Chart

From Jul 2023 to Jul 2024

Click Here for more Bayer Charts.

By Cecilia Butini


Bayer booked impairments and charges related to its agricultural business, where lower glyphosate prices weighed, leading to a widened second-quarter loss, it said Tuesday.

The German pharmaceutical and agricultural company said impairment losses of 2.30 billion euros ($2.53 billion) dragged earnings, and posted a net loss for the quarter of EUR1.88 billion. In the same quarter the previous year, the net loss had been EUR298 million.

Sales were EUR11.04 billion for the period, in line with a forecast the company gave when it revised its guidance on July 24. Earnings before interest, taxes, depreciation and amortization before special items--a key company metric--declined to EUR2.53 billion from EUR3.35 billion the previous year, in line with company expectations.

Bayer confirmed the lowered guidance it issued on July 24 due to a significant decline in sales of glyphosate-based products. The guidance includes projected sales in a range of EUR48.5 billion and EUR49.5 billion for the full year, meaning a 2% to 3% decline.

The Crop Science agricultural division is seen with a sales decline of 5%, while sales in the pharmaceutical business are expected roughly flat compared with the previous year, Bayer said.


Write to Cecilia Butini at


(END) Dow Jones Newswires

August 08, 2023 02:28 ET (06:28 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

1 Year Bayer Chart

1 Year Bayer Chart

1 Month Bayer Chart

1 Month Bayer Chart

Your Recent History

Delayed Upgrade Clock